ArticleFrontiers in neurology2018

Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up.

Maxi Kaufmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.